Clyde Pittman, MD
Plastic Surgery · Athens, GANPI 1881794519
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $14,105 of the $22,729 with a category attached, or 62.1%. AbbVie accounts for 98.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $6,161 and has fallen 76.4% since, to $1,456 in 2025. Among plastic surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 229 payments — averaging $99.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$22K
- Merz North America, Inc.$123
- Sientra, Inc.$49
- Mentor Worldwide LLC$47
- Galderma Laboratories, L.p.$47
- Bristol Myers Squibb$23
- plus $22 from 1 others
What the payments were for
- Speaking & faculty fees$14,10562%
- Food & beverage$3,19914%
- Education$250%
- Gifts$5,40024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 219 | $22,418 |
| Merz North America, Inc. | 1 | $123 |
| Sientra, Inc. | 2 | $49 |
| Mentor Worldwide LLC | 2 | $47 |
| Galderma Laboratories, L.p. | 3 | $47 |
| Bristol Myers Squibb | 1 | $23 |
| Conmed Corporation | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,729 in reported general payments places this provider in the 90th percentile of 163 plastic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 40 | $367 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 37 | $214 |
| Cephalexin | 31 | $105 |
| Metoclopramide Hcl | 41 | $25 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Athens
- James MooreAthens$5K
- David ZabelAugusta$511K
- Albert LoskenAtlanta$436K
- Jonathan NguyenAtlanta$364K
- Brian MaloneyAtlanta$224K
- Michael McNeelMarietta$160K
- Farzad NahaiAtlanta$129K
- Michael KluskaCommerce$58K
- Sara NeimanisAtlanta$51K
- Alan LarsenAtlanta$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.